RheumatoId Arthritis
Conditions
Keywords
Rheumatoid arthritis, Metabolomics, urine
Brief summary
The aim of this study is to investigate discriminant metabolites in urine from patients with rheumatoid arthritis (RA) from healthy individuals. Then we determine if the patient's metabolic fingerprint could predict the development or flare-up of RA.
Detailed description
Compare metabolites between RA patients and healthy individuals. 1. Collection urine sample 2. Assessing urine metabolites by 1H NMR spectroscopy 3. Analyzing the relationships between metabolites and clinical variables
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients with rheumatoid arthritis meet 2010 American College of Rheumatology/European League against Rheumatism classification criteria.
Exclusion criteria
* Comorbid with other autoimmune diseases * Confirmed with amyloidosis * Chronic kidney disease (estimated GFR \< 60 ml/min/1.73m2) * Chronic liver disease * Thyroid disease * Pregnancy * Solid tumor/hematologic malignancy within 5 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Metabolic fingerprint of rheumatoid arthritis | 1 years | Metabolomic analyses of urine from patients with rheumatoid arthritis, healthy controls and other autoimmune disease |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Correlations between specific metabolites and disease activity/severity of RA | 1 year | Identified metabolites and their clinical significances |